INVIVO THERAPEUTICS HOLDINGS CORP. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Invivo Therapeutics Holdings Corp. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2023.
  • Invivo Therapeutics Holdings Corp. Entity Common Stock, Shares Outstanding for the quarter ending November 3, 2023 was 3.11M shares, a 62.2% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 3.11M +1.19M +62.2% Nov 3, 2023 10-Q 2023-11-08
Q2 2023 3.11M +1.71M +123% Aug 3, 2023 10-Q 2023-08-09
Q1 2023 2.86M -31.4M -91.7% Feb 24, 2023 10-K 2023-03-01
Q3 2022 1.91M -32.3M -94.4% Nov 4, 2022 10-Q 2022-11-07
Q2 2022 1.39M -32.9M -95.9% Aug 5, 2022 10-Q 2022-08-08
Q1 2022 34.3M +80.8K +0.24% Mar 4, 2022 10-K 2022-03-07
Q3 2021 34.3M +13.1M +61.8% Nov 4, 2021 10-Q 2021-11-10
Q2 2021 34.3M +29.4M +602% Aug 11, 2021 10-Q 2021-08-13
Q1 2021 34.2M +29.3M +605% Feb 25, 2021 10-K 2021-03-01
Q3 2020 21.2M +11.7M +122% Nov 2, 2020 10-Q 2020-11-06
Q2 2020 4.88M -4.43M -47.6% Aug 7, 2020 10-Q 2020-08-11
Q1 2020 4.85M -4.46M -47.9% May 7, 2020 10-Q 2020-05-13
Q4 2019 592K Feb 14, 2020 10-K 2020-02-20
Q3 2019 9.52M +213K +2.29% Nov 4, 2019 10-Q 2019-11-07
Q2 2019 9.31M +1.55M +19.9% Aug 5, 2019 10-Q 2019-08-13
Q1 2019 9.31M -28.7M -75.5% Mar 22, 2019 10-K 2019-04-01
Q3 2018 9.31M -24.9M -72.8% Nov 1, 2018 10-Q 2018-11-08
Q2 2018 7.76M -24.4M -75.9% Aug 1, 2018 10-Q 2018-08-07
Q1 2018 38.1M +5.94M +18.5% Mar 9, 2018 10-K 2018-03-12
Q3 2017 34.2M +2.2M +6.88% Oct 28, 2017 10-Q 2017-10-30
Q2 2017 32.2M +258K +0.81% Aug 1, 2017 10-Q 2017-08-08
Q1 2017 32.1M +203K +0.64% Mar 3, 2017 10-K 2017-03-10
Q3 2016 32M +4.68M +17.1% Oct 31, 2016 10-Q 2016-11-04
Q2 2016 31.9M +4.92M +18.2% Jul 28, 2016 10-Q 2016-08-04
Q1 2016 31.9M -70.5M -68.8% May 2, 2016 10-Q 2016-05-06
Q3 2015 27.4M -66.2M -70.8% Oct 29, 2015 10-Q 2015-11-04
Q2 2015 27M -66.4M -71.1% Jul 30, 2015 10-Q 2015-08-05
Q1 2015 102M +23.4M +29.6% Mar 5, 2015 10-K 2015-03-11
Q3 2014 93.5M +14.8M +18.8% Oct 31, 2014 10-Q 2014-11-05
Q2 2014 93.4M +14.9M +18.9% Aug 1, 2014 10-Q 2014-08-06
Q1 2014 79M +12.8M +19.4% Mar 5, 2014 10-K 2014-03-17
Q3 2013 78.7M +12.9M +19.6% Nov 5, 2013 10-Q 2013-11-07
Q2 2013 78.6M +13.8M +21.2% Aug 1, 2013 10-Q 2013-08-07
Q1 2013 66.1M +2.36M +3.71% Mar 6, 2013 10-K 2013-03-12
Q3 2012 65.9M +13.8M +26.5% Nov 9, 2012 10-Q 2012-11-13
Q2 2012 64.8M +12.9M +24.9% Aug 10, 2012 10-Q 2012-08-13
Q1 2012 63.8M Mar 12, 2012 10-K 2012-03-15
Q3 2011 52M Nov 14, 2011 10-Q 2011-11-14
Q2 2011 51.9M Aug 9, 2011 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.